Plasminogen activator inhibitor 1 — Drug Target

All drugs that target Plasminogen activator inhibitor 1 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

anecortave · fendosal

Marketed (1)

• Retaane · anecortave · Ophthalmology

Phase 2 pipeline (1)

• Alnovin · fendosal · Hematology
  Alnovin works by inhibiting the activity of Plasminogen activator inhibitor 1 (PAI-1), a protein that helps regulate blood clot formation.